In limited studies, PHLDA1 has been reported to be highly expressed in pancreatic cancers as well as human intestinal tumors, while downregulation of PHLDA1 was noted during melanoma as well as breast cancer progression [31]–[35]. This evidence concerns the gene PHLDA1 and pancreatic neoplasm.